NCT00219141
Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension
See it on ClinicalTrials.gov ↗460 people
24.3%
75.7%
112 womenmiddle line = equal numbers348 men
- Phase
- PHASE3
- Paid for by
- Novartis Pharmaceuticals
- Finished
- 2007-11
- Health conditions
- Hypertension, Left Ventricular Hypertrophy, Overweight
- Who could join
- Anyone
- Ages
- 18 Years – 80 Years
- Average age
- mean 58.8 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Weight limit (BMI)
Women with a higher (or lower) body weight were turned away.
“Patients with a BMI \> 25 kg/m2”
Study titles and rules are shown in their original English.